Physician
Genesee Cancer and Blood Disease Treatment Center PC
Genesee Cancer and Blood Disease Treatment Center PC was paid $1.22M by Medicaid between Jan 2018 and Jan 2024, across 24 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 19% of everything it billed.
33Billing provider infoGENESEE CANCER AND BLOOD DISEASE TREATMENT CENTER PC
FLINT, MI 48503
FLINT, MI 48503
33aNPI1912068453assigned 12/12/2006
33bProvider typeHematology & Oncology Physician
28Total paid$1.22M
24GClaims38,760
24DCodes billed24
24AFirst – last monthJan 2018 – Jan 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Michigan
Rank by total paid#2 of 36
Median peer was paid$63K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,604 | $253K | |
| 2019 | 5,274 | $154K | |
| 2020 | 6,358 | $211K | |
| 2021 | 8,510 | $243K | |
| 2022 | 6,604 | $171K | |
| 2023 | 5,904 | $175K | |
| 2024incomplete | 506 | $17K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 4,171 | 3,863 | $233K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 16% | 3,651 | 1,794 | $202K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 14% | 4,582 | 1,019 | $171K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 13% | 1,999 | 1,812 | $162K |
| J2505 | Injection, pegfilgrastim, 6 mg | 6.8% | 20 | 13 | $83K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 5.7% | 1,326 | 962 | $69K |
| 96367 | 4.9% | 2,278 | 1,117 | $59K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 4.3% | 1,562 | 761 | $53K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.5% | 1,182 | 1,119 | $43K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.9% | 7,089 | 4,453 | $36K |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 2.3% | 141 | 96 | $28K |
| 96417 | 2.2% | 761 | 500 | $27K |
12 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 1,590 | $19K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.0% | 459 | $12K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 137 | $12K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,891 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 825 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,637 | $3K |
| 96523 | <1% | 118 | $752.69 | |
| 36591 | <1% | 78 | $677.79 | |
| 96377 | <1% | 18 | $173.50 | |
| 96415 | <1% | 16 | $142.64 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 206 | $133.71 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 23 | $46.75 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDANISH, RIZWAN (OFFICE PRESIDENT)